InvestSMART

Global Health Limited (ASX:GLH)

ALERT: Price-sensitive ASX Announcement for GLH
Current share price for GLH : $0.048 -0.017 (-26.15%)+
Announcement
Release
23 Jul 2026 9:35AM
Price at Release
$0.065
Full Release
download
Summary
Global Health Limited released its June 2026 Quarterly Business Activity Report and Appendix 4C, highlighting a 12.6% increase in customer receipts to $9.532 million over the year, and a 30% reduction in operating and investing cash outflows. The company has transitioned to a SaaS business model, reducing R&D expenses and integrating AI to enhance productivity, saving $500K. It achieved a positive cash-basis EBITDA and aims to scale revenues domestically and internationally, leveraging AI innovations. The company is exploring options for Convertible Notes maturing in 2027, including repayment from free cashflow.
Key Points
  • Customer receipts increased by 12.6% to $9.532 million.
  • Operating and investing cashflows reduced by 30%.
  • Transitioned to a SaaS business model and reduced R&D expenses.
  • AI adoption across operations saved $500K.
  • Achieved positive cash-basis EBITDA.
  • Exploring options for Convertible Notes maturing in 2027.
  • Focus on scaling revenues domestically and internationally.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.